NIIMBL is pleased to announce this Request for Application (RFA) to participate in the Viral Vector Program‘s initiative on evaluation of methods for the quality control of adeno-associated virus (AAV) aggregates.
This RFA aims to advance the understanding of AAV vector aggregation by evaluating available analytical techniques for aggregate detection, quantitation, and characterization, resulting in a recommendation on technique(s) suitable for ensuring appropriate product quality for early-stage clinical development. Learnings from the project will be openly shared across the academic, non-profit, and biotech communities that are advancing gene therapy development.
The application deadline is Tuesday, October 21, 2025.
Tuesday, September 23, 2025 | RFA Release |
Tuesday, October 21, 2025 (5 pm ET) | RFA Submission Deadline |
Mid-October – Early December, 2025 | Application Review Period |
Early December, 2025 | Award Decision Announced |
Monday, March 2, 2026 | Estimated Project Start Date |
If you have questions regarding this RFA, contact us at [email protected].
We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.